QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
OTCMKTS:RHHVF

Roche (RHHVF) Stock Price, News & Analysis

$262.13
-0.37 (-0.14%)
(As of 03/4/2024 ET)
Today's Range
$257.89
$265.20
50-Day Range
$252.91
$298.96
52-Week Range
$252.87
$323.78
Volume
574 shs
Average Volume
7,320 shs
Market Capitalization
N/A
P/E Ratio
24.25
Dividend Yield
2.98%
Price Target
N/A

RHHVF stock logo

About Roche Stock (OTCMKTS:RHHVF)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

RHHVF Stock Price History

RHHVF Stock News Headlines

Roche (OTCMKTS:RHHVF) Shares Up 2.7%
Roche Holding AG (RHHVF) Gets a Hold from Jefferies
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Roche: The Recent Sell-Off Created A 30% Upside Potential
Roche Holding AG
Barclays Keeps Their Hold Rating on Roche Holding AG (RHHVF)
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Roche Holding AG Participation (RHHVF)
Roche Holding AG Participation (RHHVF)
Roche: Leveraging Nvidia's AI For Genentech's Innovation
See More Headlines
Receive RHHVF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:RHHVF
CIK
N/A
Fax
N/A
Employees
103,605
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Severin Schwan Ph.D. (Age 57)
    Executive Chairman
    Comp: $8.52M
  • Dr. Thomas Schinecker (Age 49)
    Chief Executive Officer
    Comp: $4.39M
  • Dr. Alan Hippe (Age 57)
    Chief Financial & Information Officer
    Comp: $4.66M
  • Dr. Bruno Eschli
    Head of Investor Relations
  • Ms. Claudia Bockstiegel (Age 60)
    General Counsel
  • Ms. Pascale Schmidt (Age 51)
    Chief Compliance Officer
  • Ms. Barbara Schadler (Age 62)
    Head of Group Communications
  • Ms. Cristina A. Wilbur (Age 57)
    Chief People Officer
    Comp: $3.31M
  • Dr. Nicolas Dunant
    Head of Group Media Relations
  • Mr. Boris L. Zaitra (Age 52)
    Head of Group Business Development and M&A














RHHVF Stock Analysis - Frequently Asked Questions

How have RHHVF shares performed in 2024?

Roche's stock was trading at $285.00 at the beginning of the year. Since then, RHHVF shares have decreased by 8.0% and is now trading at $262.1266.
View the best growth stocks for 2024 here
.

Is Roche a good dividend stock?

Roche (OTCMKTS:RHHVF) pays an annual dividend of $7.80 per share and currently has a dividend yield of 3.21%. The dividend payout ratio is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Roche?

Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RHHVF) was last updated on 3/4/2024 by MarketBeat.com Staff